Medline (MDLN) Stock Price

Medline Price

NYSE·CLOSED
40.59
​
Market closed

Over the last 3 years Medline grew revenue by 9.9% annually, reaching 28.43 B USD. Earnings per share have grown at 183.4% per year over the last 2 years. For Medline, the net margin of 4.1% is up versus -0.1% a few years ago. The consensus 12-month price target for Medline is 45.00 USD, about 10.9% above where the stock trades today. Of 34 analysts, 27 rate the stock a buy — an overall Buy consensus.

Medline stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medline business model & stock analysis

Medline Inc generates revenue through its Medline Brand and Supply Chain Solutions segments. The Medline Brand offers approximately 335,000 medical-surgical products organized into Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories, serving hospitals, surgery centers, physician offices, and post-acute facilities. Supply Chain Solutions procures and distributes third-party products from national brands while providing tailored logistics and supply chain optimization services to domestic and international customers. The company's mission-critical products include surgical and procedural kits, gloves, protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Medline Brand products target healthcare facilities requiring daily mission-critical supplies, with Front Line Care focusing on immediate patient care needs, Surgical Solutions supporting operating rooms, and Laboratory and Diagnostics serving clinical testing environments. Supply Chain Solutions serves as a distribution partner for national brands, offering logistics expertise to optimize supply chains for healthcare providers across various care settings. The company's product portfolio supports all points of care, from acute to post-acute facilities, ensuring consistent product availability for daily operations. Customers purchasing Medline Brand products include hospitals, surgery centers, physician offices, and post-acute facilities, while Supply Chain Solutions serves domestic and international clients needing third-party product distribution and supply chain services. The firm's offerings cover the full range of care settings, with Surgical Solutions specifically targeting operating room environments and Laboratory and Diagnostics supporting clinical laboratories. Medline's product range ensures healthcare providers have access to essential supplies without disruption in daily operations.

Frequently asked questions about Medline

Analysts currently set an average price target of 46.33 USD for the Medline stock (median: 45.00 USD), implying +9.9 % versus the latest price. The consensus is based on 34 analyst ratings.

34 analysts currently rate the Medline stock: 27 recommend buying, 7 holding and 0 selling. For 2026, analysts expect Medline to generate revenue of 31.40 B USD and earnings per share of 2.54 USD.

Converted at the current exchange rate, the Medline share trades at 36.67 EUR (40.59 USD).

The expected revenue of Medline is 31.40 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Medline is 2.06 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medline is currently 15.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medline stock.

The price-to-sales ratio (P/S) of Medline is currently 1.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medline stock.

The Eulerpool Quality Score for Medline is 4/10.

The ISIN of Medline is US58507V1070. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Medline is MDLN. The ticker symbol is used to trade Medline shares on the stock exchange.

Fair ValueTerminal
33.28 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
1.18 M USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Dec 17, 2025
ISIN
US58507V1070
Cusip
58507V107
Market capitalization
53.32 B USDLarge Cap
52-Week Range
PEG
3.69
P/E ratio
P/Ee 2026
25.84
P/Ee 2027
26.18
P/Ee 2028
22.89
P/Ee 2029
19.96
P/Ee 2030
17.82
P/S
P/Se
1.05
EV/EBIT
28.91
P/B Ratio
4.97
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.97 %
Last updated Nov 13, 2026, 3:36 AM

Medline Peer Group

All fundamentals and in-depth analysis of Medline

Our stock analysis for Medline stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medline. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.